Kamal Adawi

Chief Financial Officer

Exagen Inc.Fate Therapeutics Inc

Insider activity · 24 months0 buys1 saleCumulative net flow

Dec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 salesNov 26 · 0 buys · 1 sale

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (6 ops.)

€69k

Latest filing published 04 Nov 2026 for Fate Therapeutics INC, €12k.

Filing timeline

BuySale

Kamal Adawi

Insider track record

Disclosed buys

Disclosed sells

Signal history

Kamal Adawi: trading record in brief

This profile gathers the share dealings of Kamal Adawi across 2 companies, led by Exagen Inc. and Fate Therapeutics Inc. The record holds 13 filings, for trades running from 23 February 2021 to 3 November 2026.

Every open-market trade on record is a sale: 6 sales worth €69k. Besides market trades, the filings include 7 share grants. So far in 2026, the count stands at no purchases and 1 sale.

The record was last updated on 4 November 2026 with an open-market sale (€12k) in Fate Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Kamal Adawi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Exagen Inc. (US)Fate Therapeutics Inc (US)

Declarations13 total

▼
Kamal Adawi
Chief Financial OfficerExecutives3 Nov 2026Fate Therapeutics Inc
13,525 USD0SEC
6,582 shares@ US$2.0548Common StockSEC:0001193125-26-447171:0
◆
Kamal Adawi
Chief Financial OfficerExecutives15 Jan 2026Fate Therapeutics Inc
0SEC
25,000 shares0Common StockSEC:0001193125-26-015323:0
◆
Kamal Adawi
Chief Financial OfficerExecutives20 Oct 2025Fate Therapeutics Inc
0SEC
75,000 shares0Common StockSEC:0001193125-25-245106:0
▼
Kamal Adawi
CFO and Corporate SecretaryExecutives4 Mar 2024Exagen Inc.
17,747 USD21SEC
9,297 shares@ US$1.908922.8% of flowCommon StockSEC:0001274737-24-000017:0
▼
Kamal Adawi
CFO and Corporate SecretaryExecutives4 Mar 2024Exagen Inc.
6,660 USD20SEC
3,487 shares@ US$1.90997.9% of flowCommon StockSEC:0001274737-24-000017:1
◆
Kamal Adawi
CFO and Corporate SecretaryExecutives20 Feb 2024Exagen Inc.
0SEC
75,000 shares0Common StockSEC:0001274737-24-000013:0
▼
Kamal Adawi
CFO and Corporate SecretaryExecutives6 Feb 2024Exagen Inc.
13,133 USD21SEC
6,738 shares@ US$1.949117.1% of flowCommon StockSEC:0001274737-24-000009:0
▼
Kamal Adawi
CFO and Corporate SecretaryExecutives2 Mar 2023Exagen Inc.
8,432 USD32SEC
3,667 shares@ US$2.299311.0% of flowCommon StockSEC:0001274737-23-000014:0
◆
Kamal Adawi
CFO and Corporate SecretaryExecutives27 Feb 2023Exagen Inc.
0SEC
100,000 shares0Common StockSEC:0001274737-23-000012:0
▼
Kamal Adawi
CFO and Corporate SecretaryExecutives8 Feb 2023Exagen Inc.
15,671 USD33SEC
5,821 shares@ US$2.692120.4% of flowCommon StockSEC:0001274737-23-000007:0
◆
Kamal Adawi
CFO and Corporate SecretaryExecutives1 Mar 2022Exagen Inc.
23,076 USD22SEC
3,241 shares@ US$7.1228.7% of flowCommon StockSEC:0001274737-22-000017:0
◆
Kamal Adawi
CFO and Corporate SecretaryExecutives4 Feb 2022Exagen Inc.
0SEC
63,500 shares0Common StockSEC:0001274737-22-000009:0
◆
Kamal Adawi
Chief Financial OfficerExecutives23 Feb 2021Exagen Inc.
0SEC
37,500 shares0Common StockSEC:0001274737-21-000010:0

13 of 13 declarations

Kamal Adawi

Insider track record

Kamal Adawi: trading record in brief

Companies and markets linked to Kamal Adawi

Similar companies

Related executives